AI assistant
Sending…
Arthur J. Gallagher & Co. — Director's Dealing 2023
Feb 9, 2023
29910_dirs_2023-02-09_eeda4e35-7df3-49d4-90f1-201d165d6dea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arthur J. Gallagher & Co. (AJG)
CIK: 0000354190
Period of Report: 2023-02-06
Reporting Person: GALLAGHER J PATRICK JR (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-06 | Common Stock | M | 62900 | $43.71 | Acquired | 82809.4435 | Direct |
| 2023-02-06 | Common Stock | F | 35085 | $193.63 | Disposed | 19909.4435 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-06 | Non-qualified Stock Option | $43.71 | M | 62900 | Disposed | 2023-03-17 | Common Stock (62900) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 23448 | Indirect |
| Common Stock | 255965 | Indirect |
| Common Stock | 94888 | Indirect |
| Common Stock | 241756 | Indirect |
| Common Stock | 218485 | Indirect |
| Common Stock | 214.625 | Indirect |
Footnotes
F1: Shares held in trust for the benefit of my children of which I am sole Trustee.
F2: Shares held in revocable trust of which my spouse is sole Trustee and as to which I disclaim beneficial ownership.
F3: Held in trust for benefit of children.
F4: One-third of this stock option becomes exerciseable on each of the 3rd, 4th, and 5th anniversaries of the grant date.
More from Arthur J. Gallagher & Co.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 24
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 23